scholarly journals Metabolic Syndrome Among Young Health Professionals in the Multicenter Latin America Metabolic Syndrome Study

2020 ◽  
Vol 18 (2) ◽  
pp. 86-95 ◽  
Author(s):  
Barbara Vizmanos ◽  
Alejandra Betancourt-Nuñez ◽  
Fabiola Márquez-Sandoval ◽  
Laura I. González-Zapata ◽  
Julia Monsalve-Álvarez ◽  
...  
2018 ◽  
Vol 35 (4) ◽  
pp. 864 ◽  
Author(s):  
Alejandra Betancourt Núñez ◽  
Fabiola Márquez Sandoval ◽  
Nancy Babio ◽  
Barbara Vizmanos

Author(s):  
Ivetteh Gaibor-Santos ◽  
Jennifer Garay ◽  
Daniela A. Esmeral-Ordoñez ◽  
Diana Rueda-García ◽  
Daniel D. Cohen ◽  
...  

2010 ◽  
Vol 14 (3) ◽  
pp. 256-263 ◽  
Author(s):  
C Alvarez ◽  
R Salazar ◽  
J Galindez ◽  
F Rangel ◽  
ML Castañeda ◽  
...  

2022 ◽  
Vol 8 (1) ◽  
pp. 5
Author(s):  
Jane Chudleigh ◽  
Jürg Barben ◽  
Clement L. Ren ◽  
Kevin W. Southern

The main aim of the present study was to explore health professionals’ reported experiences and approaches to managing children who receive a designation of cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive inconclusive diagnosis following a positive NBS result for cystic fibrosis. An online questionnaire was distributed via Qualtrics Survey Software and circulated to a purposive, international sample of health professionals involved in managing children with this designation. In total, 101 clinicians completed the online survey: 39 from the US, six from Canada, and 56 from Europe (including the UK). Results indicated that while respondents reported minor deviations in practice, they were cognizant of recommendations in the updated guidance and for the most part, attempted to implement these into practice consistently internationally. Where variation was reported, the purpose of this appeared to be to enable clinicians to respond to either clinical assessments or parental anxiety in order to improve outcomes for the child and family. Further research is needed to determine if these findings are reflective of both a wider audience of clinicians and actual (rather than reported) practice.


2018 ◽  
pp. 1-8
Author(s):  
Diana Mendoza-Cervantes ◽  
Isabel Otero ◽  
Jo Anne Zujewski ◽  
Jorge Ferrandiz Salazar ◽  
Gabriela López Córdova ◽  
...  

Purpose Cancer mortality is approximately twice as high in Latin American countries than in more developed countries. In particular, the countries of the high Andean region of Latin America carry a double burden of breast and cervical cancers. In these countries, there are disproportionately higher mortality to incidence ratios compared with other regions in Latin America. The US National Cancer Institute’s Center for Global Health, the Pan American Health Organization, and the Ministry of Health in Peru collaborated to design and execute an education and advocacy workshop in Lima, Peru. The workshop was convened to discuss regional challenges and practices, as well as to support the implementation of Plan Esperanza, Peru’s national cancer control plan. Methods Workshop participants included local and international experts to present the state of the science, health practitioners, and advocacy groups to discuss unique barriers that women in the region experience. Results Inequalities in access to and distribution of medical expertise, lack of continuity of cancer control plans, and the need for sustained public buy-in emerged as obstacles. Conclusion The workshop provided a forum to discuss key issues regarding breast and cervical cancer control among health professionals and advocates in Peru and the region. This article outlines the resulting recommendations.


2018 ◽  
Vol 107 ◽  
pp. 8-13 ◽  
Author(s):  
Kabir P. Sadarangani ◽  
Astrid Von Oetinger ◽  
Carlos Cristi-Montero ◽  
Andrea Cortínez-O'Ryan ◽  
Nicolás Aguilar-Farías ◽  
...  

2011 ◽  
Vol 14 (10) ◽  
pp. 1702-1713 ◽  
Author(s):  
F Márquez-Sandoval ◽  
G Macedo-Ojeda ◽  
D Viramontes-Hörner ◽  
JD Fernández Ballart ◽  
J Salas Salvadó ◽  
...  

AbstractObjectiveTo assess the available data on the prevalence of metabolic syndrome (MS) in Latin-American countries.DesignSystematic review. Searches were carried out in PubMed, ISIWeb, SCielo and Redalyc, using ‘metabolic syndrome x’ and ‘prevalence’ as keywords for titles and/or abstracts. Articles selected were cross-sectional studies in Latin-American countries, whose main objective was to study MS and whose study population is described below. MS must be determined using Adult Treatment Panel III criteria. Twelve studies with these criteria were selected, one of which was multi-centric.SettingLatin America.SubjectsApparently healthy subjects aged 18–65 years (including young adult, mature adult and elderly populations) of both genders.ResultsThe general prevalence (weighted mean) of MS in Latin-American countries was 24·9 (range: 18·8–43·3) %. MS was slightly more frequent in women (25·3 %) than in men (23·2 %), and the age group with the highest prevalence of MS consisted of those over 50 years of age. The most frequent components of MS were low HDL cholesterol levels (62·9 %) and abdominal obesity (45·8 %). Similar outcomes were obtained from the multi-centre study on Latin-American populations analysed.ConclusionsThe present review brings us closer to an understanding of the prevalence of MS in Latin-American countries. However, it is not possible to know the full scope of the problem, partly because data from some countries are not available, and because the methodological differences among the studies published up to the present limit a joint analysis of their results.


2015 ◽  
Vol 7 (1) ◽  
Author(s):  
Fernanda de Carvalho Vidigal ◽  
Andréia Queiroz Ribeiro ◽  
Nancy Babio ◽  
Jordi Salas-Salvadó ◽  
Josefina Bressan

Nutrients ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 2566
Author(s):  
Soraia Poloni ◽  
Bruna Bento dos Santos ◽  
Ana Chiesa ◽  
Norma Specola ◽  
Marcela Pereyra ◽  
...  

This study aimed to describe the current practices in the diagnosis and dietary management of phenylketonuria (PKU) in Latin America, as well as the main barriers to treatment. We developed a 44-item online survey aimed at health professionals. After a pilot test, the final version was sent to 25 practitioners working with inborn errors of metabolism (IEM) in 14 countries. Our results include 22 centers in 13 countries. Most countries (12/13) screened newborns for PKU. Phenylalanine (Phe) targets at different ages were very heterogeneous among centers, with greater consistency at the 0–1 year age group (14/22 sought 120–240 µmol/L) and the lowest at >12 years (10 targets reported). Most countries had only unflavored powdered amino acid substitutes (10/13) and did not have low-protein foods (8/13). Only 3/13 countries had regional databases of the Phe content of foods, and only 4/22 centers had nutrient analysis software. The perceived obstacles to treatment were: low purchasing power (62%), limited/insufficient availability of low-protein foods (60%), poor adherence, and lack of technical resources to manage the diet (50% each). We observed a heterogeneous scenario in the dietary management of PKU, and most countries experienced a lack of dietary resources for both patients and health professionals.


Sign in / Sign up

Export Citation Format

Share Document